Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids?

Since the commercialization of morphine in 1826, numerous alkaloids have been isolated and exploited effectively for the betterment of mankind, including cancer treatment. However, the commercialization of alkaloids as anticancer agents has generally been limited by serious side effects due to their...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jian Sheng Loh, Li Kar Stella Tan, Wai Leng Lee, Long Chiau Ming, Chee Wun How, Jhi Biau Foo, Nurolaini Kifli, Bey Hing Goh, Yong Sze Ong
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/07a906a40cd945d1a5c8859d61338706
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares